BeneSmile™ is a patented, slow-melt oral microbiome support tablet designed for the long unprotected interval between brushing cycles — especially overnight.
Brushing, flossing, and mouthwash are short contact-time interventions. They matter — but they do not occupy the entire overnight biological window. Plaque ecology operates for hours while you sleep, and no product has been designed specifically to address this gap.
Salivary flow naturally slows during sleep, reducing the mouth's natural cleansing mechanism and leaving plaque ecology unchecked for six to eight hours every night.
Oral bacteria adhere, metabolize substrates, form biofilm, and generate acids or volatile compounds between brushing cycles — including overnight.
Mints and breath products are largely cosmetic. Probiotic lozenges are usually single-mechanism. No product has been purpose-built for overnight oral ecology support.
A slow-melt oral fitness tablet placed after bedtime brushing, designed to extend active-ingredient contact with teeth, gums, and the oral microbiome through the critical overnight window.
“Our objective is not simply therapeutic intervention after disease has developed. Our philosophy is to help maintain microbiome balance and resilience before disease occurs.”
Dental caries is the most common chronic disease in the United States — chronic, cumulative, and largely preventable. BeneSmile™ is designed to intercept that cascade upstream, before it compounds into decades of cost.
BeneSmile™ is an 800 mg slow-melt tablet engineered to dissolve over 10–15 minutes, keeping actives in contact with saliva, teeth, gumline, and biofilm surfaces during the key application window.
BeneSmile is built as a complete oral ecology system, not a single-ingredient story. Each vector works independently — together, they are synergistic and scientifically coherent.
Antibody-based oral ecology support. Antigen-recognition targeting logic that provides technology differentiation and IP positioning unique to BeneSmile.
Xylitol, erythritol, tagatose, and allulose — a non-cariogenic, biofilm-aware sweetener architecture that supports plaque-metabolism interference rather than just flavoring.
Trace mineral support for breath, attachment, and microbial signaling pathways. Taste-constrained below the metallic sensation threshold for daily compliance.
Bacillus coagulans and Bacillus subtilis provide transient oral ecology support without requiring long-term colonization. They survive oral passage and germinate in the gut.
An 800 mg tablet designed for a 10–15 minute melt profile — maintaining contact with saliva, teeth, gumline, and biofilm surfaces during the critical overnight window.
Stimulated salivary flow helps disperse dissolved actives across the oral environment and supports the mouth's own natural clearance mechanisms.
Our scientific substantiation program builds proof deliberately — starting with bench screening and progressing through mechanism panels, pilot human use, and commercial validation.
Saliva and biofilm models. CFU count. S. mutans reduction. pH profile. Biofilm mass measurements. Complete formula vs. formula-without-IgY-antibodies comparison.
GTF activity assays. Adhesion and biofilm assays. Zinc compatibility testing. Rare sugar blend effects. Sporebiotic contribution analysis.
Small consumer and dental-office pilot study: breath perception, oral cleanliness scoring, plaque index directionality, tolerance, taste, and compliance.
Reviews and repeat purchase data. Subscription retention. Dentist sampling conversion. Channel-specific sales velocity and professional-channel pull.
An overview of passive immunoglobulin Y technology and its application to oral microbiome support, including the clinical evidence from Hatta et al. (Caries Research, 1997) and subsequent research.
Available on RequestA review of xylitol, erythritol, tagatose, and allulose in the context of plaque ecology, biofilm inhibition, and enamel remineralization support.
Available on RequestA review of the evidence linking oral microbiome health to cardiovascular risk, cognitive outcomes, and metabolic function — and the role of daily oral ecology support.
Available on RequestBeneSmile is designed around two complementary use occasions — one at the end of the day, one at the beginning.
Place one BeneSmile tablet in your mouth after your nighttime brushing routine. Allow it to dissolve slowly over 10–15 minutes before sleep. During those hours, the active system continues working — supporting your oral microbiome balance, fresh breath, and healthy gum and tooth support while salivary flow is at its lowest.
An optional morning use before brushing can help loosen overnight biofilm, supporting the mechanical outcome of your brushing routine. Use as a "bookend" to complete the overnight oral fitness cycle.
BeneSmile is designed to be scientifically coherent — a product that dental professionals can understand, explain to patients, and recommend with confidence. We offer professional sampling, practice materials, and white paper access.
Sampling packs, patient education materials, and the full scientific rationale for BeneSmile's multi-vector mechanism. Request your professional kit below.
BeneSmile connects oral microbiome support to systemic wellness — the oral-gut axis, immune checkpoint function, and the broader health implications of overnight plaque ecology.
BeneSmile is positioned for premium natural and specialty retail, dental channel distribution, and Amazon DTC. Contact us to discuss placement and co-packing options.
We welcome conversations with ingredient suppliers, manufacturers, and oral health companies interested in the MultiVector Complex™ platform. A formal partner package is available on request.
Whether you're a consumer curious about BeneSmile, a dental professional seeking samples, a distributor, or a potential strategic partner — we want to hear from you.
Message received.
We'll be in touch shortly. If you requested samples or white papers, expect a response within one business day.